| m/f | Age (yr) | SCPE | GMFCS Score | RF-DRG-left | RF-DRG-right | Indication | VAS pre | Improvement | VAS post | Δ-VAS | Side-effects | Hip morphology | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  |  |  |  |  | spast | pain | care |  | spast | pain | care |  |  |  | left | right |
1 | f | 18 | 2 | V | L1-3 | - | Â | â–ª | Â | 8 | Â | + | Â | 2 | 6 | no | III | V |
2 | f | 22 | 2 | V | L1-4 | - | â–ª | â–ª | Â | 10 | + | + | Â | 1.5 | 8.5 | no | ns | ns |
3 | f | 10 | 2 | V | L1-2 | L1-2 | â–ª | â–ª | Â | 10 | + | Â | Â | 8 | 2 | no | V | III |
4 | m | 16 | 2 | V | L1-3 | - | Â | â–ª | Â | 7 | Â | + | Â | 3 | 4 | no | II | V |
5 | m | 16 | 2 | V | L1-4 | - | â–ª | â–ª | Â | 8.2 | Â | + | Â | 1.6 | 6.6 | no | IV | V |
6 | m | 7 | 2 | V | - | L1-3 | â–ª | Â | Â | ns | Â | Â | Â | ns | Â | yes | 0 | III |
7 | m | 5 | 2 | V | L1-3 | L1-3 | â–ª | Â | â–ª | ns | Â | Â | + | ns | Â | no | IV | IV |
8 | f | 11 | 2 | V | L1-2 | - | Â | â–ª | Â | 6 | Â | + | Â | 2 | 4 | no | * | II |
9 | f | 10 | 2 | V | L1-2 | - | â–ª | â–ª | â–ª | 8 | Â | + | + | 5.5 | 2.5 | no | I | I |
 | f | 12 | 2 | V | L1-2 | - | ▪ | ▪ | ▪ | 8 |  | + | + | 5 | 3 | no | I | I |
 | f | 14 | 2 | V | L1-2 | - | ▪ | ▪ | ▪ | 10 |  |  |  | 10 | 0 | no | I | I |
10 | m | 5 | 2 | V | L1-4 | L1-4 | â–ª | Â | â–ª | ns | + | Â | Â | ns | Â | no | II | V |
11 | f | 16 | 2 | V | L1-4 | L1-4 | â–ª | â–ª | â–ª | 8.7 | + | + | + | 3.1 | 5.6 | no | ns | ns |